Shayne & Jacobs LLC Lowers Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Shayne & Jacobs LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 96,041 shares of the company’s stock after selling 240 shares during the quarter. HCA Healthcare accounts for approximately 9.8% of Shayne & Jacobs LLC’s holdings, making the stock its 2nd biggest holding. Shayne & Jacobs LLC’s holdings in HCA Healthcare were worth $39,034,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. CreativeOne Wealth LLC acquired a new position in HCA Healthcare during the 1st quarter worth about $231,000. New Mexico Educational Retirement Board lifted its position in HCA Healthcare by 29.9% during the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares in the last quarter. Bessemer Group Inc. lifted its position in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after buying an additional 2,584 shares in the last quarter. Empowered Funds LLC lifted its position in HCA Healthcare by 54.3% during the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock valued at $4,639,000 after purchasing an additional 4,893 shares during the period. Finally, Swedbank AB acquired a new position in HCA Healthcare during the 1st quarter valued at about $95,882,000. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,345 shares of company stock valued at $5,747,945 in the last quarter. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

Shares of HCA opened at $363.75 on Friday. The stock has a market capitalization of $95.27 billion, a P/E ratio of 18.13, a P/E/G ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a twelve month low of $220.55 and a twelve month high of $417.14. The company has a 50 day moving average of $395.26 and a 200-day moving average of $352.63. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same period last year, the business earned $4.29 earnings per share. The firm’s revenue was up 10.3% on a year-over-year basis. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.73%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HCA. Deutsche Bank Aktiengesellschaft upped their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. UBS Group upped their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $365.00 to $395.00 and gave the company an “equal weight” rating in a research report on Tuesday. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Finally, Royal Bank of Canada increased their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Five investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $377.17.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.